04/02/2021
The arrival of Kaftrio for many people with CF has raised the potential for reducing treatment burden by stopping other therapies.
We've been working with a team of academics to plan a national study to assess stopping some nebulised therapies after commencing Kaftrio. This study will be carried out to examine whether it is safe to stop some nebulised therapies, and if the results are positive they will inform best practice for CF teams, people with CF and their families.
If funded by the government (announcement expected during September), the trial will be called CF STORM.
You can discuss this trial with your CF team, or sign up to our clinical trials newsletter to receive updates www.cysticfibrosis.org.uk/clinical-trials-newsletter
If you wish to stop one of your CF therapies this is something that should be discussed and undertaken in partnership with your CF team